- Home
- CCL vs ONC Comparison
CCL vs ONC Comparison
Compare CCL & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCL | ONC |
|---|---|---|
| Founded | 1972 | 2010 |
| Country | United States | Switzerland |
| Employees | N/A | 12000 |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2B | 31.4B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | CCL | ONC |
|---|---|---|
| Price | $25.64 | $297.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 22 | 10 |
| Target Price | $33.99 | ★ $385.10 |
| AVG Volume (30 Days) | ★ 20.7M | 178.5K |
| Earning Date | 03-27-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | ★ 40.28 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $18,881,000,000.00 | N/A |
| Revenue This Year | $5.69 | $723.76 |
| Revenue Next Year | $3.52 | $15.04 |
| P/E Ratio | ★ $139.68 | $614.06 |
| Revenue Growth | ★ 7.83 | N/A |
| 52 Week Low | $19.22 | $228.93 |
| 52 Week High | $34.03 | $385.22 |
Technical Indicators
Market Signals| Indicator | CCL | ONC |
|---|---|---|
| Relative Strength Index (RSI) | 43.27 | 45.12 |
| Support Level | $24.34 | $283.56 |
| Resistance Level | $27.34 | $300.00 |
| Average True Range (ATR) | 1.07 | 6.45 |
| MACD | -0.19 | -1.76 |
| Stochastic Oscillator | 6.31 | 20.73 |
Price Performance
Historical ComparisonAbout CCL Carnival Corporation
Carnival is the largest global cruise company, with more than 90 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.
About ONC BeiGene Ltd. American Depositary Shares
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.